Library — CHDR

Search

Filter

AVOID; a phase III, randomised controlled trial using indocyanine green for the prevention of anastomotic leakage in colorectal surgery.

Meijer RPJ, Faber RA, Bijlstra OD, Braak JPBM, Meershoek-Klein Kranenbarg E, Putter H, Mieog JSD, Burggraaf K, Vahrmeijer AL, Hilling DE,

BMJ open, 2022 Apr; 12(4):e051144

View publication
Near-Infrared Fluorescence Tumor-Targeted Imaging in Lung Cancer: A Systematic Review

Lisanne K. A. Neijenhuis, Lysanne D. A. N. de Myunck , Okker D. Bijlstra , Peter J. K. Kuppen , Denise E. Hilling , Frank J. Borm, Danielle Cohen, J. Sven D. Mieog, Willem H. Steup , Jerry Braun, Jacobus Burggraaf, Alexander L. Vahrmeijer and Merlijn Hutteman

Life, 2022 Mar

View publication
Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial

Selinde S. Wind, Manon A. A. Jansen, Melanie Rijsbergen, Michiel J. van Esdonk, Dimitrios Ziagkos, Wing C. Cheng, Tessa Niemeyer-van der Kolk, John Korsten, Agnieszka Gruszka, Debora Schmitz-Rohmer, David Bonnel, Raphael Legouffe, Florian Barré, Marcel W. Bekkenk, Ellen R. M. de Haas, Koen D. Quint, Melanie Rolli, Henk Johan Streefkerk, Jacobus Burggraaf, Maarten H. Vermeer and Robert Rissmann

Cancers, 2022 Mar

View publication
Cardiac age detected by machine learning applied to the surface ECG of healthy subjects: Creation of a benchmark.

van der Wall HEC, Hassing GJ, Doll RJ, van Westen GJP, Cohen AF, Selder JL, Kemme M, Burggraaf J, Gal P

Journal of electrocardiology, 2022 Mar

View publication
Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patients.

Thijssen E, den Heijer JM, Puibert D, van Brummelen EMJ, Naranda T, Groeneveld GJ

Parkinsonism & related disorders, 2022 Mar

View publication
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder

Francis M Dijkstra, Aurora JAE van de Loo, Smedra Abdulahad, Else R Bosma, Mitch Hartog, Hendrikje Huls, Dianne C Kuijper, Esther de Vries, Bhavna Solanki, Jaskaran Singh, Leah Aluisio, Peter Zannikos, Frederik E Stuurman, Gabriël E Jacobs, Joris C Verster

Journal of Psychopharmacology, 2022 Feb

View publication
Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients.

Moss LM, Algera MH, Dobbins R, Gray F, Strafford S, Heath A, van Velzen M, Heuberger JAAC, Niesters M, Olofsen E, Laffont CM, Dahan A, Groeneveld GJ

PloS one, 2022 Feb; 17(1):e0256752

View publication
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.

Saghari M, Gal P, Gilbert S, Yateman M, Porter-Brown B, Brennan N, Quaratino S, Wilson R, Grievink HW, Klaassen ES, Bergmann KR, Burggraaf J, van Doorn MBA, Powell J, Moerland M, Rissmann R

Clinical pharmacology and therapeutics, 2022 Jan

View publication
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study.

Ruijs TQ, Heuberger JAAC, de Goede AA, Ziagkos D, Otto ME, Doll RJ, van Putten MJAM, Groeneveld GJ

British journal of clinical pharmacology, 2022 Jan

View publication

«
1
2
3
4
5
6
7
8
...
87
88
»